These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33718008)

  • 1. The difference of social cognitive and neurocognitive performance between patients with schizophrenia at different stages and influencing factors.
    Chen S; Liu Y; Liu D; Zhang G; Wu X
    Schizophr Res Cogn; 2021 Jun; 24():100195. PubMed ID: 33718008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of cognitive function in Chinese first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) profile of impairment.
    Zhang H; Wang Y; Hu Y; Zhu Y; Zhang T; Wang J; Ma K; Shi C; Yu X; Li C
    Gen Psychiatr; 2019; 32(3):e100043. PubMed ID: 31423473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.
    Wu JQ; Chen DC; Tan YL; Xiu MH; De Yang F; Soares JC; Zhang XY
    Psychiatry Res; 2016 Apr; 238():196-202. PubMed ID: 27086233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive deficits profiles in the first-episode of schizophrenia, clinical high risk of psychosis, and genetically high-risk of psychosis.
    Dong F; Mao Z; Ding Y; Wang L; Bo Q; Li F; Wang F; Wang C
    Front Psychiatry; 2023; 14():1292141. PubMed ID: 38146278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The relationship of resilience with cognitive function in patients with first-episode schizophrenia].
    Wu JY; Xia XW; Liu T; Zhao JS; Dai JM; Li ZN; Chen C; Qiu Y; Han ZL; Wei QL
    Zhonghua Yi Xue Za Zhi; 2021 Oct; 101(37):3006-3011. PubMed ID: 34638192
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the Chinese version of the MATRICS Consensus Cognitive Battery to assess cognitive functioning in individuals with high risk for psychosis, first-episode schizophrenia and chronic schizophrenia: a systematic review and meta-analysis.
    Cai B; Zhu Y; Liu D; Li Y; Bueber M; Yang X; Luo G; Su Y; Grivel MM; Yang LH; Qian M; Stone WS; Phillips MR
    Lancet Reg Health West Pac; 2024 Apr; 45():101016. PubMed ID: 38699289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cognitive impairment on social function and quality of life in chronic schizophrenia].
    Chen SY; Wen F; Zhao CB; Zhang DM; Wu XL
    Zhonghua Yi Xue Za Zhi; 2020 Feb; 100(5):351-356. PubMed ID: 32074778
    [No Abstract]   [Full Text] [Related]  

  • 9. An empirical evaluation of the MATRICS Consensus Cognitive Battery in bipolar disorder.
    Van Rheenen TE; Rossell SL
    Bipolar Disord; 2014 May; 16(3):318-25. PubMed ID: 24119238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences of neurocognitive functioning in patients with first-episode schizophrenia in China.
    Pu C; Qiu Y; Zhou T; Yang F; Lu Z; Wang C; Deng H; Zhao J; Shi C; Yu X
    Compr Psychiatry; 2019 Nov; 95():152132. PubMed ID: 31669790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
    Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.
    McCleery A; Ventura J; Kern RS; Subotnik KL; Gretchen-Doorly D; Green MF; Hellemann GS; Nuechterlein KH
    Schizophr Res; 2014 Aug; 157(1-3):33-9. PubMed ID: 24888526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of Cognition Patterns Measured by MATRICS Consensus Cognitive Battery (MCCB) among First Episode Schizophrenia Patients and Their Biological Parents.
    Cao A; Shen T; Li H; Wu C; McCabe M; Mellor D; Byrne L; Zhang J; Huang J; Peng D; Xu Y
    Shanghai Arch Psychiatry; 2017 Jun; 29(3):154-160. PubMed ID: 28904510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery.
    Bezdicek O; Michalec J; Kališová L; Kufa T; Děchtěrenko F; Chlebovcová M; Havlík F; Green MF; Nuechterlein KH
    Schizophr Res; 2020 Apr; 218():85-92. PubMed ID: 32089475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential of Frequency and Duration Mismatch Negativity and Theta Power Deficits in First-Episode and Chronic Schizophrenia.
    Xiong YB; Bo QJ; Wang CM; Tian Q; Liu Y; Wang CY
    Front Behav Neurosci; 2019; 13():37. PubMed ID: 30894804
    [No Abstract]   [Full Text] [Related]  

  • 16. Subcortical Brain Volumes Relate to Neurocognition in First-Episode Schizophrenia, Bipolar Disorder, Major Depression Disorder, and Healthy Controls.
    Shi J; Guo H; Liu S; Xue W; Fan F; Li H; Fan H; An H; Wang Z; Tan S; Yang F; Tan Y
    Front Psychiatry; 2021; 12():747386. PubMed ID: 35145436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring Cognition in Bipolar Disorder with Psychosis Using the MATRICS Consensus Cognitive Battery.
    Sperry SH; O'Connor LK; Öngür D; Cohen BM; Keshavan MS; Lewandowski KE
    J Int Neuropsychol Soc; 2015 Jul; 21(6):468-72. PubMed ID: 26154947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum NCAM levels and cognitive deficits in first episode schizophrenia patients versus health controls.
    An H; Zhou L; Yu Y; Fan H; Fan F; Tan S; Wang Z; Z B; Shi J; Yang F; Zhang X; Tan Y; Huang XF
    Schizophr Res; 2018 Feb; 192():457-458. PubMed ID: 28624138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognition and social cognition in remitted first-episode schizophrenia: correlation with VEGF serum levels.
    Zhao Y; Xiao W; Chen K; Zhan Q; Ye F; Tang X; Zhang X
    BMC Psychiatry; 2019 Dec; 19(1):403. PubMed ID: 31842818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers.
    Stone WS; Mesholam-Gately RI; Giuliano AJ; Woodberry KA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; McCarley RW; Heinssen R; Green MF; Nuechterlein K; Seidman LJ
    Schizophr Res; 2016 Apr; 172(1-3):106-13. PubMed ID: 26896388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.